M
Manfred S. Green
Researcher at University of Haifa
Publications - 293
Citations - 9435
Manfred S. Green is an academic researcher from University of Haifa. The author has contributed to research in topics: Population & Incidence (epidemiology). The author has an hindex of 50, co-authored 281 publications receiving 8346 citations. Previous affiliations of Manfred S. Green include Tel Aviv University & Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Health Aspects of Climate Change in Cities with Mediterranean Climate, and Local Adaptation Plans.
TL;DR: Recommendations are suggested for Med-cities in various aspects, depending on their local needs and vulnerability challenges: assessment of health risks, extreme events management and long-term adaptation, among others.
Journal ArticleDOI
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
T.A. Swartz,Manfred S. Green,Manfred S. Green,R. Handscher,Danit Sofer,M. Cohen-Dar,M. Cohen-Dar,Tamar Shohat,S. Habib,E. Barak,Z. Dror,Eli Somekh,T. Peled-Leviathan,R. Yulzari,A. Libling,E. Mendelson,E. Mendelson,Lester M. Shulman +17 more
TL;DR: The principal factor for interruption of disease and virus transmission in the community was a strong and persistent humoral immunity with immunological memory and a satisfactory level of family hygiene contributed towards breaking the chain of transmission of poliovirus to contacts.
Journal ArticleDOI
Sibship size as a risk factor for hepatitis a infection
Manfred S. Green,Yona Zaaide +1 more
TL;DR: Findings provide strong evidence for the role of siblings in the spread of hepatitis A infection and appear to explain a large part of the ethnic differences in antibody status.
Journal ArticleDOI
Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults.
Dani Cohen,Dani Cohen,Nadav Orr,Moti Haim,Shai Ashkenazi,Shai Ashkenazi,Guy Robin,Manfred S. Green,Manfred S. Green,Moshe Ephros,Moshe Ephros,Tamar Sela,Raphael Slepon,Isaac Ashkenazi,Isaac Ashkenazi,David N. Taylor,Ann-Mari Svennerholm,Arieh Eldad,Arieh Eldad,Joshua Shemer,Joshua Shemer +20 more
TL;DR: Two double-blind placebo-controlled, randomized trials were performed among 155 healthy volunteers to evaluate the safety and immunogenicity of different lots of the oral, killed ETEC vaccine consisting of two doses of whole cells plus recombinantly produced cholera toxin B subunit.